Genetic Engineering Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063420
  • May 2021
  • Biotechnology
  • 116 Pages
Download Sample
The Genetic Engineering Drug market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Genetic Engineering Drug market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Shanghai Lansheng Guojian Pharmaceutical, Biotech Pharmaceutical, GeneScience Pharmaceuticals, Beijing SL Pharmaceutical, Anhui Anke Biotechnology, 3SBio, Jiangsu Sihuan Bioengineering, Tonghua Dongbao Pharmaceutical, Shenzhen Neptunus Interlong Bio-Technique, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Genetic Engineering Drug market along with their effects over the forecast period. Similarly, according to the region Genetic Engineering Drug market research report includes the study of opportunities available in the market situation.

The Genetic Engineering Drug market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Genetic Engineering Drug Market:
The Genetic Engineering Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Shanghai Lansheng Guojian Pharmaceutical, Biotech Pharmaceutical, GeneScience Pharmaceuticals, Beijing SL Pharmaceutical, Anhui Anke Biotechnology, 3SBio, Jiangsu Sihuan Bioengineering, Tonghua Dongbao Pharmaceutical, Shenzhen Neptunus Interlong Bio-Technique, Others

Genetic Engineering Drug Market Segmentation Analysis:
By Product Type
Monoclonal Antibody
Recombinant Human Erythropoietin
Recombinant Human Interferon
Recombinant Human Growth Hormone
Recombinant Human Insulin
End users
Pharmaceutical Industries
Academic Institutes
Agriculture
Others


Global Genetic Engineering Drug Market Segmentation by Regions:
In regional analysis, Genetic Engineering Drug market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Genetic Engineering Drug market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Genetic Engineering Drug Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Genetic Engineering Drug Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Genetic Engineering Drug Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Genetic Engineering Drug Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Genetic Engineering Drug Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Genetic Engineering Drug market, according to the key region.
  • To study the Genetic Engineering Drug market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Genetic Engineering Drug market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Genetic Engineering Drug research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Genetic Engineering Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Genetic Engineering Drug market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Genetic Engineering Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Genetic Engineering Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Genetic Engineering Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Shanghai Lansheng Guojian Pharmaceutical
  • Biotech Pharmaceutical
  • GeneScience Pharmaceuticals
  • Beijing SL Pharmaceutical
  • Anhui Anke Biotechnology
  • 3SBio
  • Jiangsu Sihuan Bioengineering
  • Tonghua Dongbao Pharmaceutical
  • Shenzhen Neptunus Interlong Bio-Technique
  • Others
  • Monoclonal Antibody
  • Recombinant Human Erythropoietin
  • Recombinant Human Interferon
  • Recombinant Human Growth Hormone
  • Recombinant Human Insulin
  • Pharmaceutical Industries
  • Academic Institutes
  • Agriculture
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Genetic Engineering Drug Market Snapshot
          2.1.1. Global Genetic Engineering Drug Market By Product Type,2019
               2.1.1.1.Monoclonal Antibody
               2.1.1.2.Recombinant Human Erythropoietin
               2.1.1.3.Recombinant Human Interferon
               2.1.1.4.Recombinant Human Growth Hormone
               2.1.1.5.Recombinant Human Insulin
          2.1.2. Global Genetic Engineering Drug Market By End Users,2019
               2.1.2.1.Pharmaceutical Industries
               2.1.2.2.Academic Institutes
               2.1.2.3.Agriculture
               2.1.2.4.Others
          2.1.3. Global Genetic Engineering Drug Market By End-use,2019
          2.1.4. Global Genetic Engineering Drug Market By Geography,2019

3. Global Genetic Engineering Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Genetic Engineering Drug Market Size (US$), By Product Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product Type, 2020
     4.2. Global Genetic Engineering Drug Market Size (US$), By Product Type, 2018 – 2028

5. Global Genetic Engineering Drug Market Size (US$), By End Users, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End Users, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End Users, 2020
     5.2. Global Genetic Engineering Drug Market Size (US$), By End Users, 2018 – 2028

6. Global Genetic Engineering Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Genetic Engineering Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Genetic Engineering Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Genetic Engineering Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Genetic Engineering Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Genetic Engineering Drug Market Size (US$), By Product Type, 2018 – 2028
          7.2.3. North America Genetic Engineering Drug Market Size (US$), By End Users, 2018 – 2028
          7.2.4. North America Genetic Engineering Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Genetic Engineering Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Genetic Engineering Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Genetic Engineering Drug Market Size (US$), By Product Type, 2018 – 2028
          7.3.3. Europe Genetic Engineering Drug Market Size (US$), By End Users, 2018 – 2028
          7.3.4. Europe Genetic Engineering Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Genetic Engineering Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Genetic Engineering Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Genetic Engineering Drug Market Size (US$), By Product Type, 2018 – 2028
          7.4.3. Asia Pacific Genetic Engineering Drug Market Size (US$), By End Users, 2018 – 2028
          7.4.4. Asia Pacific Genetic Engineering Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Genetic Engineering Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Genetic Engineering Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Genetic Engineering Drug Market Size (US$), By Product Type, 2018 – 2028
          7.5.3. Latin America Genetic Engineering Drug Market Size (US$), By End Users, 2018 – 2028
          7.5.4. Latin America Genetic Engineering Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Genetic Engineering Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Genetic Engineering Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Genetic Engineering Drug Market Size (US$), By Product Type, 2018 – 2028
          7.6.3. MEA Genetic Engineering Drug Market Size (US$), By End Users, 2018 – 2028
          7.6.4. MEA Genetic Engineering Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Genetic Engineering Drug Providers
        8.4.1 Shanghai Lansheng Guojian Pharmaceutical
                8.4.1.1 Business Description
                8.4.1.2 Shanghai Lansheng Guojian Pharmaceutical Geographic Operations
                8.4.1.3 Shanghai Lansheng Guojian Pharmaceutical Financial Information
                8.4.1.4 Shanghai Lansheng Guojian Pharmaceutical Product Positions/Portfolio
                8.4.1.5 Shanghai Lansheng Guojian Pharmaceutical Key Developments
        8.4.2 Biotech Pharmaceutical
                8.4.2.1 Business Description
                8.4.2.2 Biotech Pharmaceutical Geographic Operations
                8.4.2.3 Biotech Pharmaceutical Financial Information
                8.4.2.4 Biotech Pharmaceutical Product Positions/Portfolio
                8.4.2.5 Biotech Pharmaceutical Key Developments
        8.4.3 GeneScience Pharmaceuticals
                8.4.3.1 Business Description
                8.4.3.2 GeneScience Pharmaceuticals Geographic Operations
                8.4.3.3 GeneScience Pharmaceuticals Financial Information
                8.4.3.4 GeneScience Pharmaceuticals Product Positions/Portfolio
                8.4.3.5 GeneScience Pharmaceuticals Key Developments
        8.4.4 Beijing SL Pharmaceutical
                8.4.4.1 Business Description
                8.4.4.2 Beijing SL Pharmaceutical Geographic Operations
                8.4.4.3 Beijing SL Pharmaceutical Financial Information
                8.4.4.4 Beijing SL Pharmaceutical Product Positions/Portfolio
                8.4.4.5 Beijing SL Pharmaceutical Key Developments
        8.4.5 Anhui Anke Biotechnology
                8.4.5.1 Business Description
                8.4.5.2 Anhui Anke Biotechnology Geographic Operations
                8.4.5.3 Anhui Anke Biotechnology Financial Information
                8.4.5.4 Anhui Anke Biotechnology Product Positions/Portfolio
                8.4.5.5 Anhui Anke Biotechnology Key Developments
        8.4.6 3SBio
                8.4.6.1 Business Description
                8.4.6.2 3SBio Geographic Operations
                8.4.6.3 3SBio Financial Information
                8.4.6.4 3SBio Product Positions/Portfolio
                8.4.6.5 3SBio Key Developments
        8.4.7 Jiangsu Sihuan Bioengineering
                8.4.7.1 Business Description
                8.4.7.2 Jiangsu Sihuan Bioengineering Geographic Operations
                8.4.7.3 Jiangsu Sihuan Bioengineering Financial Information
                8.4.7.4 Jiangsu Sihuan Bioengineering Product Positions/Portfolio
                8.4.7.5 Jiangsu Sihuan Bioengineering Key Developments
        8.4.8 Tonghua Dongbao Pharmaceutical
                8.4.8.1 Business Description
                8.4.8.2 Tonghua Dongbao Pharmaceutical Geographic Operations
                8.4.8.3 Tonghua Dongbao Pharmaceutical Financial Information
                8.4.8.4 Tonghua Dongbao Pharmaceutical Product Positions/Portfolio
                8.4.8.5 Tonghua Dongbao Pharmaceutical Key Developments
        8.4.9 Shenzhen Neptunus Interlong Bio-Technique
                8.4.9.1 Business Description
                8.4.9.2 Shenzhen Neptunus Interlong Bio-Technique Geographic Operations
                8.4.9.3 Shenzhen Neptunus Interlong Bio-Technique Financial Information
                8.4.9.4 Shenzhen Neptunus Interlong Bio-Technique Product Positions/Portfolio
                8.4.9.5 Shenzhen Neptunus Interlong Bio-Technique Key Developments
        8.4.10 Others
                8.4.10.1 Business Description
                8.4.10.2 Others Geographic Operations
                8.4.10.3 Others Financial Information
                8.4.10.4 Others Product Positions/Portfolio
                8.4.10.5 Others Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Genetic Engineering Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Genetic Engineering Drug Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Genetic Engineering Drug Market Revenue, By End Users, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Genetic Engineering Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Genetic Engineering Drug Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Genetic Engineering Drug Market Revenue, By End Users, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Genetic Engineering Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Genetic Engineering Drug Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Genetic Engineering Drug Market Revenue, By End Users, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Genetic Engineering Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Genetic Engineering Drug Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Genetic Engineering Drug Market Revenue, By End Users, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Genetic Engineering Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Genetic Engineering Drug Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Genetic Engineering Drug Market Revenue, By End Users, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Genetic Engineering Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Genetic Engineering Drug: Market Segmentation 
FIG. 2 Global Genetic Engineering Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Genetic Engineering Drug Market, By Product Type, 2019 (US$ Mn) 
FIG. 5 Global Genetic Engineering Drug Market, By End Users, 2019 (US$ Mn) 
FIG. 6 Global Genetic Engineering Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Genetic Engineering Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Genetic Engineering Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Genetic Engineering Drug Providers, 2019
FIG. 11 Global Genetic Engineering Drug Market Revenue Contribution, By Product Type, 2019 & 2028 (Value %) 
FIG. 12 Global Genetic Engineering Drug Market Revenue Contribution, By End Users, 2019 & 2028 (Value %) 
FIG. 13 Global Genetic Engineering Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Genetic Engineering Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Genetic Engineering Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Genetic Engineering Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Genetic Engineering Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Genetic Engineering Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Genetic Engineering Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Genetic Engineering Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Genetic Engineering Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Genetic Engineering Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Genetic Engineering Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Genetic Engineering Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Genetic Engineering Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Genetic Engineering Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Genetic Engineering Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Genetic Engineering Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Genetic Engineering Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Genetic Engineering Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Genetic Engineering Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Genetic Engineering Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Genetic Engineering Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Genetic Engineering Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Genetic Engineering Drug Market Value, By Country, 2018 – 2028
TABLE  Shanghai Lansheng Guojian Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biotech Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GeneScience Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Beijing SL Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Anhui Anke Biotechnology: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  3SBio: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Jiangsu Sihuan Bioengineering: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Tonghua Dongbao Pharmaceutical: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shenzhen Neptunus Interlong Bio-Technique: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Others: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Genetic Engineering Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Genetic Engineering Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Genetic Engineering Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Genetic Engineering Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Genetic Engineering Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Genetic Engineering Drug Providers, 2016
FIG.  Global Genetic Engineering Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Recombinant Human Erythropoietin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Recombinant Human Interferon Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Recombinant Human Growth Hormone Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Recombinant Human Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Genetic Engineering Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Academic Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Agriculture Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Genetic Engineering Drug Market Value, 2018 – 2028, (US$ Mn)